171 related articles for article (PubMed ID: 28350789)
1. Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer.
Shen J; Liao Y; Hopper JL; Goldberg M; Santella RM; Terry MB
Br J Cancer; 2017 Apr; 116(9):1229-1233. PubMed ID: 28350789
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Eng SM; Sagiv SK; Paykin AB; Wang Q; Hayes S; Teitelbaum SL; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2053-8. PubMed ID: 15598760
[TBL] [Abstract][Full Text] [Related]
3. Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: An evaluation of effect measure modification by body mass index and weight change.
Niehoff N; White AJ; McCullough LE; Steck SE; Beyea J; Mordukhovich I; Shen J; Neugut AI; Conway K; Santella RM; Gammon MD
Environ Res; 2017 Jan; 152():17-25. PubMed ID: 27741445
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
Shen J; Gammon MD; Terry MB; Wang L; Wang Q; Zhang F; Teitelbaum SL; Eng SM; Sagiv SK; Gaudet MM; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):336-42. PubMed ID: 15734955
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.
Gaudet MM; Gammon MD; Bensen JT; Sagiv SK; Shantakumar S; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
Breast Cancer Res Treat; 2008 Mar; 108(1):93-9. PubMed ID: 17624591
[TBL] [Abstract][Full Text] [Related]
6. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer.
Rundle A; Tang D; Hibshoosh H; Estabrook A; Schnabel F; Cao W; Grumet S; Perera FP
Carcinogenesis; 2000 Jul; 21(7):1281-9. PubMed ID: 10874004
[TBL] [Abstract][Full Text] [Related]
7. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females.
Shantakumar S; Gammon MD; Eng SM; Sagiv SK; Gaudet MM; Teitelbaum SL; Britton JA; Terry MB; Paykin A; Young TL; Wang LW; Wang Q; Stellman SD; Beyea J; Hatch M; Camann D; Prokopczyk B; Kabat GC; Levin B; Neugut AI; Santella RM
J Expo Anal Environ Epidemiol; 2005 Nov; 15(6):482-90. PubMed ID: 15856074
[TBL] [Abstract][Full Text] [Related]
8. Aromatic DNA adducts and breast cancer risk: a case-cohort study within the EPIC-Spain.
Agudo A; Peluso M; Munnia A; Luján-Barroso L; Barricarte A; Amiano P; Navarro C; Sánchez MJ; Quirós JR; Ardanaz E; Larrañaga N; Tormo MJ; Chirlaque MD; Rodríguez-Barranco M; Sánchez-Cantalejo E; Cellai F; Bonet C; Sala N; González CA
Carcinogenesis; 2017 Jul; 38(7):691-698. PubMed ID: 28535209
[TBL] [Abstract][Full Text] [Related]
9. Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer.
Sagiv SK; Gaudet MM; Eng SM; Abrahamson PE; Shantakumar S; Teitelbaum SL; Bell P; Thomas JA; Neugut AI; Santella RM; Gammon MD
Environ Res; 2009 Apr; 109(3):287-91. PubMed ID: 19181313
[TBL] [Abstract][Full Text] [Related]
10. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts.
Gammon MD; Santella RM; Neugut AI; Eng SM; Teitelbaum SL; Paykin A; Levin B; Terry MB; Young TL; Wang LW; Wang Q; Britton JA; Wolff MS; Stellman SD; Hatch M; Kabat GC; Senie R; Garbowski G; Maffeo C; Montalvan P; Berkowitz G; Kemeny M; Citron M; Schnabel F; Schuss A; Hajdu S; Vinceguerra V
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):677-85. PubMed ID: 12163319
[TBL] [Abstract][Full Text] [Related]
11. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.
White AJ; Chen J; McCullough LE; Xu X; Cho YH; Teitelbaum SL; Neugut AI; Terry MB; Hibshoosh H; Santella RM; Gammon MD
Cancer Causes Control; 2015 Dec; 26(12):1791-802. PubMed ID: 26407953
[TBL] [Abstract][Full Text] [Related]
12. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue.
Rundle A; Tang D; Zhou J; Cho S; Perera F
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1079-85. PubMed ID: 11045791
[TBL] [Abstract][Full Text] [Related]
13. IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk.
Shen J; Terry MB; Gammon MD; Gaudet MM; Teitelbaum SL; Eng SM; Sagiv SK; Neugut AI; Santella RM
Breast Cancer Res Treat; 2006 Sep; 99(1):1-7. PubMed ID: 16752224
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk.
Crew KD; Gammon MD; Terry MB; Zhang FF; Agrawal M; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM
Carcinogenesis; 2007 Dec; 28(12):2548-51. PubMed ID: 17962219
[TBL] [Abstract][Full Text] [Related]
15. Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis.
Gammon MD; Sagiv SK; Eng SM; Shantakumar S; Gaudet MM; Teitelbaum SL; Britton JA; Terry MB; Wang LW; Wang Q; Stellman SD; Beyea J; Hatch M; Kabat GC; Wolff MS; Levin B; Neugut AI; Santella RM
Arch Environ Health; 2004 Dec; 59(12):640-9. PubMed ID: 16789472
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in DNA repair genes, traffic-related polycyclic aromatic hydrocarbon exposure and breast cancer incidence.
Mordukhovich I; Beyea J; Herring AH; Hatch M; Stellman SD; Teitelbaum SL; Richardson DB; Millikan RC; Engel LS; Shantakumar S; Steck SE; Neugut AI; Rossner P; Santella RM; Gammon MD
Int J Cancer; 2016 Jul; 139(2):310-21. PubMed ID: 26946191
[TBL] [Abstract][Full Text] [Related]
17. Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors.
Mordukhovich I; Rossner P; Terry MB; Santella R; Zhang YJ; Hibshoosh H; Memeo L; Mansukhani M; Long CM; Garbowski G; Agrawal M; Gaudet MM; Steck SE; Sagiv SK; Eng SM; Teitelbaum SL; Neugut AI; Conway-Dorsey K; Gammon MD
Environ Health Perspect; 2010 Apr; 118(4):511-8. PubMed ID: 20064791
[TBL] [Abstract][Full Text] [Related]
18. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study.
Tang D; Rundle A; Mooney L; Cho S; Schnabel F; Estabrook A; Kelly A; Levine R; Hibshoosh H; Perera F
Breast Cancer Res Treat; 2003 Mar; 78(2):217-22. PubMed ID: 12725421
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure.
Bonner MR; Han D; Nie J; Rogerson P; Vena JE; Muti P; Trevisan M; Edge SB; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):53-60. PubMed ID: 15668476
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.
Shen J; Gammon MD; Terry MB; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
Eur J Cancer; 2008 Mar; 44(5):710-7. PubMed ID: 18053706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
